Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it enclosed the schedule of analyst/institutional investors meeting that the Company would be participating on 28th and 30th September 2021. The schedule shall be subject to changes, if any.
The above information is a part of company’s filings submitted to BSE.